Nzube Ruth Amaeze
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nzube Ruth Amaeze has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Branden Joshua Damus
Department of Microbiology and Immunology, University of Miami, Coral Gables, FL 33146, USA
1 shared publication - Eunsoo Yoo
Chemical, Biological, and Bioengineering Department, North Carolina Agricultural and Technical State University, Greensboro, NC 27411, USA.
1 shared publication - Gagandeep Kaur
Department of Chemistry, Howard University, Washington, DC 20059, USA
1 shared publication
Latest Publications
- Open Access
Ethoxy Acetalated Dextran-Based Biomaterials for Therapeutic Applications
A novel class of pH-responsive polymers, acetalated dextran, has emerged in the field of biomaterials. These versatile materials are derived from dextran through a simple acetalation reaction, allowing for the creation of polymers with a tunable release profile which allows the controlled release of encapsulated therapeutics in response to acidic environments. Despite their recent introduction, acetalated dextran has rapidly garnered significant interest due to its potential for various therapeutic applications. This review delves specifically into the recent advancements of ethoxy acetalated dextran or Ace-DEX, a particular acetalated dextran with a distinct advantage: its degradation products (acetone and ethanol) are less toxic compared to other variants that produce methanol. The focus of this review is the diverse range of biomedical applications currently being explored for Ace-DEX-based scaffolds. Finally, this review concludes by addressing the existing challenges associated with Ace-DEX and outlining potential future research directions within this promising field.
Open AccessEthoxy Acetalated Dextran-Based Biomaterials for Therapeutic Applications
A novel class of pH-responsive polymers, acetalated dextran, has emerged in the field of biomaterials. These versatile materials are derived from dextran through a simple acetalation reaction, allowing for the creation of polymers with a tunable release profile which allows the controlled release of encapsulated therapeutics in response to acidic environments. Despite their recent introduction, acetalated dextran has rapidly garnered significant interest due to its potential for various therapeutic applications. This review delves specifically into the recent advancements of ethoxy acetalated dextran or Ace-DEX, a particular acetalated dextran with a distinct advantage: its degradation products (acetone and ethanol) are less toxic compared to other variants that produce methanol. The focus of this review is the diverse range of biomedical applications currently being explored for Ace-DEX-based scaffolds. Finally, this review concludes by addressing the existing challenges associated with Ace-DEX and outlining potential future research directions within this promising field.